Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox)

American Journal of Cardiology

Volumn 115, Issue 5, 2015, Pages 557-562

  Reddy, Vanessa S ^a   Bui, Quang T ^b   Jacobs, Joan R ^c   Begelman, Susan M ^c   Miller, Dave P ^d   French, William J ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c GENENTECH INC   (United States)

^d ICON CLINICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; FEMALE; HEART MUSCLE NECROSIS; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SENSITIVITY ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; ACUTE PHASE RESPONSE; BLOOD; COHORT ANALYSIS; FACTUAL DATABASE; HEART INFARCTION; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

ACUTE-PHASE REACTION; AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; TRIGLYCERIDES; UNITED STATES;

EID: 84922901871     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.12.006     Document Type: Article

References (21)

1. D. Duffy, D.N. Holmes, M.T. Roe, and E.D. Peterson The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction Am Heart J 163 2012 705 713
2. S.A. Murphy, C.P. Cannon, S.D. Wiviott, C.H. McCabe, and E. Braunwald Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22) trial J Am Coll Cardiol 54 2009 2358 2362
3. S.C. Smith Jr., J. Allen, S.N. Blair, R.O. Bonow, L.M. Brass, G.C. Fonarow, S.M. Grundy, L. Hiratzka, D. Jones, H.M. Krumholz, L. Mosca, T. Pearson, M.A. Pfeffer, and K.A. Taubert AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute J Am Coll Cardiol 47 2006 2130 2139
4. A. Sniderman, G. Thanassoulis, P. Couture, K. Williams, A. Alam, and C.D. Furberg Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein lowering J Clin Lipidol 6 2012 303 309
5. W.J. French, V.S. Reddy, and H.V. Barron Transforming quality of care and improving outcomes after acute MI: lessons from the National Registry of Myocardial Infarction JAMA 308 2012 771 772
6. W.J. Rogers, L.J. Bowlby, N.C. Chandra, W.J. French, J.M. Gore, C.T. Lambrew, R.M. Rubison, A.J. Tiefenbrunn, and W.D. Weaver Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction Circulation 90 1994 2103 2114
7. W.J. Rogers, J.G. Canto, C.T. Lambrew, A.J. Tiefenbrunn, B. Kinkaid, D.A. Shoultz, P.D. Frederick, and N. Every Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3 J Am Coll Cardiol 36 2000 2056 2063
8. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith Jr., and N.J. Stone Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
9. American Diabetes Association Standards of medical care in diabetes - 2011 Diabetes Care 34 Suppl 1 2011 S11 S61
10. National Cholesterol Education Program (NCEP) Exert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
11. B. Pitt, J. Loscalzo, J. Ycas, and J.S. Raichlen Lipid levels after acute coronary syndromes J Am Coll Cardiol 51 2008 1440 1445
12. R.S. Rosenson Myocardial injury: the acute phase response and lipoprotein metabolism J Am Coll Cardiol 22 1993 933 940
13. M. Fahie-Wilson, R. Mills, and K. Wilson HDL cholesterol and the acute phase reaction following myocardial infarction and acute pancreatitis Clin Chim Acta 167 1987 197 209
14. L.C. Correia, M.S. Rocha, and J.P. Esteves HDL-cholesterol level provides additional prognosis in acute coronary syndromes Int J Cardiol 136 2009 307 314
15. A.G. Olsson, G.G. Schwartz, M. Szarek, W.J. Sasiela, M.D. Ezekowitz, P. Ganz, M.F. Oliver, D. Waters, and A. Zeiher High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial Eur Heart J 26 2005 890 896
16. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, D.X. Zhao, J.L. Anderson, A.K. Jacobs, J.L. Halperin, N.M. Albert, R.G. Brindis, M.A. Creager, D. DeMets, R.A. Guyton, J.S. Hochman, R.J. Kovacs, F.G. Kushner, E.M. Ohman, W.G. Stevenson, and C.W. Yancy 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 2013 e362 e425
17. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer, and A.M. Skene Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
18. F.A. Spencer, R.J. Goldberg, J.M. Gore, K.A. Fox, A. Avezum, G. Agnelli, L. Kritharides, F.A. Anderson, S.G. Goodman, G. FitzGerald, J. Allegrone, and D. Brieger Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl Am J Cardiol 100 2007 913 918
19. M.D. Carroll, B. Kit, and D.A. Lacher Total and High-density Lipoprotein Cholesterol in Adults: National Health and Nutrition Examination Survey, 2009-2010 2013 Available at: http://www.cdc.gov/nchs/data/databriefs/db92.pdf Accessed on October 2013
20. N.A. Dreyer, S.R. Tunis, M. Berger, D. Ollendorf, P. Mattox, and R. Gliklich Why observational studies should be among the tools used in comparative effectiveness research Health Aff (Millwood) 29 2010 1818 1825
21. S.S. Martin, M.J. Blaha, M.B. Elshazly, E.A. Brinton, P.P. Toth, J.W. McEvoy, P.H. Joshi, K.R. Kulkarni, P.D. Mize, P.O. Kwiterovich, A.P. DeFilippis, R.S. Blumenthal, and S.R. Jones Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications J Am Coll Cardiol 62 2013 732 739